Kope Green

Anter

• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO nā pī "Kope Green" nā hua kope (nā pī) o nā hua Coffea ʻaʻole i hoʻomoʻa ʻia. ʻO ke kaʻina hana moʻa e hoʻemi i ka nui o kahi kemikino i kapa ʻia ʻo ka chlorogen acid. No laila, ʻoi aku ka kiʻekiʻe o nā kōmole kope ʻōmaʻomaʻo i ke kiʻekiʻe o ka chlorogenic acid ke hoʻohālikelike ʻia i nā pīni kope kope mau ʻia. Manaʻo ʻia ʻo Chlorogenic acid i ke kofe ʻōmaʻomaʻo e loaʻa i nā pono olakino.

Ua lilo ke kofe ʻōmaʻomaʻo i mea kaulana no ka pohō kaumaha ma hope o ka ʻōlelo ʻia ma ka hōʻike ʻo Kauka Oz i ka makahiki 2012. Ua hōʻike ʻia ka hōʻike a Kauka Oz iā ia ma ke ʻano he "The green coffee bean that burns fat fast" a koi ʻia ʻaʻole pono ka hoʻoikaika kino a me ka papaʻai paha.

Lawe nā kānaka i ke kope ʻōmaʻomaʻo no ka momona, ka maʻi kō, ke koko kiʻekiʻe, a me nā kūlana ʻē aʻe, akā ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i ka hapa nui o kēia mau hoʻohana.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no KOPE GREEN penei:

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• Piʻi koko kiʻekiʻe. Hōʻike ka noiʻi mua i ka lawe ʻana i ka kope kope ʻōmaʻomaʻo a hiki i nā hebedoma he 12 e hoʻohaʻahaʻa haʻahaʻa i ke kahe o ke koko i nā mākua me ke kaomi kiʻekiʻe kiʻekiʻe.
• ʻO kahi hui o nā hōʻailona e hoʻonui i ka makaʻi o ka maʻi kō, ka maʻi puʻuwai, a me ka hahau (metabolic syndrome). Hōʻike ka noiʻi mua i ka lawe ʻana i ka kope kope ʻōmaʻomaʻo e hoʻemi i ke kahe o ke koko a me ke kō i ke kō e kahi mea liʻiliʻi i nā mākua me kēia ʻano. Akā ʻaʻole i hoʻomaikaʻi ʻia ke kō kō a me nā kiʻekiʻe o ke kolesterol a me nā mea momona ʻē aʻe.
• Ka momona. Lawe i ka ʻemi kope ʻōmaʻomaʻo no 8-12 mau pule e hōʻemi i ke kaupaona e kahi liʻiliʻi loa i nā mākua a i ʻole nā ​​mākua me ka momona.
• Kolesterol kiʻekiʻe.
• Maʻi Alzheimer.
• Diabetes.
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ke kofe ʻōmaʻomaʻo no kēia mau hoʻohana.

ʻO nā pīni kope ʻōmaʻomaʻo nā pī kope ʻaʻole i hoʻomoʻa ʻia. Aia i loko o kēia mau piʻa kope ke kiʻekiʻena o ka kemikolo chlorogenic acid. Kuhi ʻia kēia kemika i nā pono olakino. No ke koko kiʻekiʻe e pili paha i nā kīʻaha koko i hoʻemi ʻia ke koko.

No ka pohō kaumaha, manaʻo ʻia ʻo ka chlorogenic acid i ke kope ʻōmaʻomaʻo e hoʻopili i ka hopena o ke kino i ke kō a me ka metabolism.

Ke lawe ʻia e ka waha: Kope ʻōmaʻomaʻo SAFE MAU PONO ke lawe kūpono ʻia. ʻO nā mea kope kope ʻōmaʻomaʻo i lawe ʻia i nā kaha a i ka 480 mg i kēlā me kēia lā i hoʻohana palekana ʻia a hiki i nā hebedoma 12. Eia kekahi, ua hoʻohana palekana ʻia kahi kope kope ʻōmaʻomaʻo kikoʻī (Svetol, Naturex) i nā kaha a hiki i ka 200 mg ʻelima mau manawa i kēlā me kēia lā a hiki i nā hebedoma 12.

Loaʻa i ka kope ʻōmaʻomaʻo ka caffeine Aia ka ʻoi aku ka liʻiliʻi o ka caffeine i ke kope ʻōmaʻomaʻo ma mua o ke kofe maʻamau. Akā hiki i ke kofe ʻōmaʻomaʻo ke kumu i nā hopena ʻē aʻe e pili ana i ka caffeine e like me ke kope. Hoʻopili kēia i ka hiamoe ʻole, ka makaʻu a me ka hoʻomaha ʻole, ka huhū o ka ʻōpū, ka palaho a me ka luaʻi, ka piʻi ʻana o ka puʻuwai a me ka hanu ʻana, a me nā hopena ʻē aʻe. ʻO ka ʻai ʻana paha i nā kofe he nui paha he kumu ʻeha ka poʻo, ka hopohopo, ka pīhoihoi, ke kani ʻana o nā pepeiao, a me nā puʻuwai puʻuwai ʻole.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻAʻole lawa ka ʻike hilinaʻi e ʻike ai inā palekana ke kofe ʻōmaʻomaʻo e hoʻohana i ka wā hāpai a hānai umauma paha. Noho ma ka ʻaoʻao palekana a pale i ka hoʻohana.

Nā kiʻekiʻe kiʻekiʻe o ka homositistine: Ke hoʻopau nei i kahi lāʻau kiʻekiʻe o ka waikawa chlorogenic no kahi manawa pōkole ua hoʻonui ʻia ka nui o nā homosisteine ​​plasma, i pili pū ʻia me nā ʻano e like me ka maʻi puʻuwai.

Nā pilikia kūpilikiʻi: ʻO ka caffeine i loko o ke kofe ʻōmaʻomaʻo e hoʻonui i ka hopohopo.

Nā maʻi hōʻeha: Aia kekahi hopohopo o ka caffeine i loko o ka kofe ʻōmaʻomaʻo eʻoi aku ka maikaʻi o ke kahe ʻana o ke kahe.

Diabetes: Ke hōʻike nei kekahi mau noiʻi i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e loli paha i ke ala o ka poʻe me ka maʻi kō i ke kō. Ua hōʻike ʻia ʻo Caffeine ke kumu o ka hoʻonui a me ka hōʻemi ʻana i ke kō kō. E hoʻohana i ka caffeine me ke akahele inā he maʻi diabetes kou a nānā pono i kāu kō kō.

Pohā: Aia ka kofe ʻōmaʻomaʻo caffeine. ʻO ka caffeine i loko o ke kofe, keu hoʻi i ka lawe ʻia i ka nui, hiki ke hōʻino i ka maʻi pākī.

Epilepsy: Aia ka kofe ʻōmaʻomaʻo caffeine. Pono ka poʻe me ka maʻi epilepsy e hōʻalo i ka hoʻohana ʻana i ka caffeine ma nā kaha kiʻekiʻe. Pono e hoʻohana akahele i nā lāʻau haʻahaʻa o ka caffeine.

Glaucoma: Lawe i ka caffeine i loko o ke kofe ʻōmaʻomaʻo hiki ke hoʻonui i ke kaomi i loko o ka maka. Hoʻomaka ka hoʻonui ma waena o 30 mau minuke a mau ma ka liʻiliʻi he 90 mau minuke.

Piʻi koko kiʻekiʻe: Lawe i ka caffeine i loaʻa i ke kofe ʻōmaʻomaʻo e hoʻonui i ke kahe o ke koko i ka poʻe me ke koko kiʻekiʻe. Eia nō naʻe, ʻoi aku ka liʻiliʻi o kēia hopena i ka poʻe e ʻai i ka caffeine mai ke kope ʻōmaʻomaʻo a i ʻole nā ​​kumuwaiwai ʻē aʻe i nā manawa āpau.

ʻO ka maʻi huhū huhū (IBS): Aia ka kofe ʻōmaʻomaʻo caffeine. ʻO ka caffeine i loko o ke kofe ʻōmaʻomaʻo, keu hoʻi i ka lawe ʻia i ka nui, e hoʻomāhuahua paha i ka diarrhea o kekahi poʻe me IBS.

Nā iwi lahilahi (osteoporosis): ʻO ka caffeine mai ke kope ʻōmaʻomaʻo a me nā kumuwaiwai ʻē aʻe hiki ke hoʻonui i ka nui o ka puna i hoʻoheheʻe ʻia i ka mimi. E hoʻonāwaliwali paha kēia i nā iwi. Inā loaʻa iā ʻoe ka osteoporosis, palena i ka ʻai ʻana o ka caffeine ma lalo o 300 mg i kēlā me kēia lā. Hiki ke kōkua i ka lawe ʻana i nā mea hoʻoliʻiliʻi calcium e hana no ka calcium i nalowale. Inā maikaʻi ʻoe olakino a loaʻa ka lawa ʻana o ka calcium mai kāu meaʻai a i ʻole nā ​​mea hoʻopihapiha, lawe a 400 mg o ka caffeine i kēlā me kēia lā (ma kahi o 20 mau kīʻaha kope ʻōmaʻomaʻo) ʻaʻole e hoʻonui i ka makaʻu o ka loaʻa ʻana o ka osteoporosis. ʻO nā wahine Postmenopausal i loaʻa kahi ʻano hoʻoilina e mālama iā lākou mai ka hana ʻana i ka wikamina D maʻamau, e akahele loa i ka hoʻohana ʻana i ka caffeine.

Kānāwai

E akahele me kēia hui ʻana.

Adenosine (Adenocard)

Hiki paha i ka caffeine i ke kope ʻōmaʻomaʻo ke ālai i nā hopena o adenosine (Adenocard). Hoʻohana pinepine ʻia ʻo Adenosine (Adenocard) e nā kauka e hana i kahi hōʻike ma ka puʻuwai. Kapa ʻia kēia hōʻike he hoʻāʻo koʻikoʻi puʻuwai. E hōʻoki i ka ʻai ʻana i ke kofe ʻōmaʻomaʻo a i ʻole nā ​​huahana i loaʻa i ka caffeine ma ka liʻiliʻi he 24 mau hola ma mua o ka hoʻāʻo ʻana o ka naʻau koʻikoʻi.

ʻAlekohola (Ethanol)

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki i ka waiʻona ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i ke kofe ʻōmaʻomaʻo me ka wai ʻona ka mea e nui ai ka caffeine i ke kahe o ke koko a me nā hopena ʻaoʻao e like me ka jitteriness, headache, a me ke kuʻi puʻuwai wikiwiki.

Alendronate (Fosamax)

Hiki i ka kofe ʻōmaʻomaʻo ke hoʻēmi i ka nui o ka alendronate (Fosamax) e ʻānai ai ke kino. Lawe i ka kope ʻōmaʻomaʻo a me alendronate (Fosamax) i ka manawa like e hoʻoliʻiliʻi paha i ka maikaʻi o ka alendronate (Fosamax). Mai lawe i ka kofe ʻōmaʻomaʻo i loko o ʻelua mau hola o ka lawe ʻana i ka alendronate (Fosamax).

ʻO Clozapine (Clozaril)

Haki ke kino i ka clozapine (Clozaril) e hemo ai. Hiki i ka caffeine i ke kofe ʻōmaʻomaʻo ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka clozapine (Clozaril). ʻO ka lawe ʻana i ke kofe ʻōmaʻomaʻo me ka clozapine (Clozaril) hiki ke hoʻonui i nā hopena a me nā hopena ʻē aʻe o ka clozapine (Clozaril).

Dipyridamole (Persantine)

Hiki paha i ka caffeine i ke kofe ʻōmaʻomaʻo ke ālai i nā hopena o dipyridamole (Persantine). Hoʻohana pinepine ʻia ʻo Dipyridamole (Persantine) e nā kauka e hana i kahi hōʻike ma ka puʻuwai. Kapa ʻia kēia hōʻike he hoʻāʻo koʻikoʻi puʻuwai. E hōʻoki i ka lawe ʻana i ka kofe ʻōmaʻomaʻo a i ʻole nā ​​huahana i loaʻa i ka caffeine ma ka liʻiliʻi he 24 mau hola ma mua o ka hoʻāʻo ʻana o ka naʻau

ʻO Disulfiram (Antabuse)

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki i ka Disulfiram (Antabuse) ke hōʻemi i ka wikiwiki o ke kino e hoʻopau i ka caffeine. Lawe i ka kofe ʻōmaʻomaʻo me disulfiram (Antabuse) e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o ke kofe ʻōmaʻomaʻo e like me ka jitteriness, hyperactivity, hoʻonāukiuki, a me nā mea ʻē aʻe.

Ephedrine

Hoʻoikaika ka lāʻau lapaʻau stimulant i ka ʻōnaehana hopohopo. ʻO ka caffeine i loko o ke kofe ʻōmaʻomaʻo a me ka ephedrine nā lāʻau stimulant ʻelua. ʻO ka lawe ʻana i ka kofe ʻōmaʻomaʻo a me ka ephedrine e kumu nui ai ka hoʻonāukiuki ʻana a i kekahi manawa he hopena koʻikoʻi a me nā pilikia puʻuwai. Mai lawe i nā huahana i loaʻa i ka caffeine a me ka ephedrine i ka manawa like.

ʻO Estrogens

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki i nā Estrogens ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i nā huaale estrogen a me ke kope ʻōmaʻomaʻo e hoʻonāukiuki paha i ka jitteriness, headache, heartbeat wikiwiki, a me nā hopena ʻē aʻe.Inā ʻoe e inu i nā huaale estrogen kaohi i kāu lawe ʻana i ka caffeine.

ʻO kekahi o nā pila estrogen me nā conjugated equine estrogens (Premarin), ethinyl estradiol, estradiol, a me nā mea ʻē aʻe.

Fluvoxamine (Luvox)

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki i ka Fluvoxamine (Luvox) ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i ka caffeine me fluvoxamine (Luvox) paha ke kumu o ka caffeine i loko o ke kino, a hoʻonui i nā hopena a me nā hopena ʻē aʻe o ka caffeine.

Likiuma

Lawe maoli kou kino i ka lithium. Hiki i ka caffeine i ke kope ʻōmaʻomaʻo ke hoʻonui i ka wikiwiki o ka hoʻopau ʻana o kou kino i ka lithium. Inā lawe ʻoe i nā huahana i loaʻa ka caffeine a lawe ʻoe i ka lithium, e hoʻōki mālie i ka lawe ʻana i nā huahana caffeine. ʻO ke kū koke ʻana i ka caffeine hiki ke hoʻonui i nā hopena ʻē aʻe o ka lithium.

Nā lāʻau no ka hānō (Beta-adrenergic agonists)

Loaʻa i ka kope ʻōmaʻomaʻo ka caffeine Hiki i ka cafeeine ke hoʻoulu i ka naʻau. Hiki i kekahi mau lāʻau no ka hānō ke hoʻoulu i ka puʻuwai. Lawe i ka caffeine me kekahi mau lāʻau no ka hānō e hoʻonāukiuki paha i ka nui a hoʻonā i nā pilikia o ka puʻuwai.

ʻO kekahi mau lāʻau no ka hānō e pili pū me ka albuterol (Proventil, Ventolin, Volmax), metaproterenol (Alupent), terbutaline (Bricanyl, Brethine), a me isoproterenol (Isuprel).

Nā lāʻau no ke kaumaha (MAOI)

Hiki i ka caffeine i ke kofe ʻōmaʻomaʻo ke hoʻoulu i ke kino. Hiki i kekahi mau lāʻau i hoʻohana ʻia no ke kaumaha ke hoʻoulu i ke kino. ʻO ka lawe ʻana i ka kofe ʻōmaʻomaʻo a me ka lawe ʻana i kekahi mau lāʻau no ke kaumaha e hoʻonāukiuki paha a me nā hopena ʻē aʻe me ka puʻuwai wikiwiki, ke koko kiʻekiʻe, ka makaʻu, a me nā mea ʻē aʻe.

ʻO kekahi o kēia mau lāʻau i hoʻohana ʻia no ke kaumaha me phenelzine (Nardil), tranylcypromine (Parnate), a me nā mea ʻē aʻe.

Nā lāʻau i hoʻolohi i ke kō ʻana o ke koko (Anticoagulant / Antiplatelet drug)

ʻO ka cafe i loko o ke kofe ʻōmaʻomaʻo e lohi paha i ke kāpili ʻana o ke koko. ʻO ka lawe ʻana i ke kofe ʻōmaʻomaʻo me nā lāʻau lapaʻau e hōʻemi ai i ka ʻōpala ʻana e hoʻonui ai i ka manawa o ka ʻeha a me ke kahe ʻana.

ʻO kekahi mau lāʻau e lohi ai ke kāpili ʻana o ke koko me aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, a me nā mea ʻē aʻe), ibuprofen (Advil, Motrin, a me nā mea ʻē aʻe), naproxen (Anaprox, Naprosyn, a me nā mea ʻē aʻe), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), a me nā mea ʻē aʻe.

Nikotine

ʻO ka lawe ʻana i ka caffeine i loko o ke kope ʻōmaʻomaʻo me ka nikotine e hoʻonui ai i ka wikiwiki o ka puʻuwai a me ke kaomi koko.

Pentobarbital (Nembutal)

Hiki i nā hopena stimulant o ka caffeine i ke kofe ʻōmaʻomaʻo ke pale i nā hopena hana hiamoe o pentobarbital.

Phenylpropanolamine

Hiki i ka caffeine i ke kofe ʻōmaʻomaʻo ke hoʻoulu i ke kino. Hiki i ka Phenylpropanolamine ke hoʻoulu i ke kino. Lawe pū paha i ka caffeine a me phenylpropanolamine e hoʻonāukiuki nui a hoʻonui i ka puʻuwai, ke kahe o ke koko, a hoʻomaka i ka hopohopo.

Riluzole (Rilutek)

Haki ke kino i ka riluzole (Rilutek) e hemo ai. Hiki i ka lawe ʻana i ke kofe ʻōmaʻomaʻo ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka riluzole (Rilutek). I ke kumumanaʻo, hoʻohana pinepine ʻia e hoʻonui i nā hopena a me nā hopena ʻē aʻe o riluzole.

Nā lāʻau hoʻāla

Hoʻoikaika ka lāʻau lapaʻau stimulant i ka ʻōnaehana hopohopo. Ma ka wikiwiki ʻana i ka ʻōnaehana, hiki i nā lāʻau stimulant ke hoʻohoka iā ʻoe a wikiwiki i kou puʻuwai puʻuwai. Hiki i ka caffeine i ke kofe ʻōmaʻomaʻo ke wikiwiki i ka ʻōnaehana hopohopo. Lawe i ka kofe ʻōmaʻomaʻo me nā lāʻau stimulant i kumu e pilikia ai e like me ka hoʻonui ʻia o ka puʻuwai a me ke kahe kiʻekiʻe. Hōʻalo i ka lawe ʻana i nā lāʻau stimulant me ke kope ʻōmaʻomaʻo.

Kekahi stimulant ai 'o diethylpropion (Tenuate), epinephrine, phentermine (Ionamin), pseudoephedrine (Sudafed), a me na mea e ae he nui.

ʻO Theophylline

Hana like ka caffeine i ke kofe ʻōmaʻomaʻo me ka theophylline. Hiki i ka cafe ke hoʻemi i ka wikiwiki o ke kino e hemo i ka theophylline. ʻO ka lawe ʻana i ke kofe ʻōmaʻomaʻo a me ka lawe ʻana i ka theophylline e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o ka theophylline.

Verapamil (Calan, kekahi)

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki iā Verapamil ke hōʻemi i ka wikiwiki o ke kino e hoʻopau i ka caffeine. ʻO ka inu ʻana i ka kope a me ka lawe ʻana i ka verapamil hiki ke hoʻonui i ka hopena o nā hopena ʻaoʻao no ke kope ʻōmaʻomaʻo e like me ka jitteriness, headache, a me ka hoʻonui ʻana o ka puʻuwai.

Mea liʻiliʻi

E makaʻala me kēia hui pū.

Nā Antibiotics (antibiotic Quinolone)

Hōʻoki ke kino i ka caffeine mai ke kope ʻōmaʻomaʻo e kāpae aku. Hiki i kekahi mau lāʻau ke hōʻemi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i kēia mau lāʻau me ke kofe ʻōmaʻomaʻo e hoʻonui paha i ka hopena o nā hopena ʻē aʻe e like me ka jitteriness, headache, hoʻonui ka nui o ka puʻuwai, a me nā mea ʻē aʻe.

ʻO kekahi mau antibiotic e hoʻemi i ka wikiwiki o ke kino e wāwahi i ka caffeine e komo pū ana me ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), a me nā mea ʻē aʻe.

Nā lāʻau hoʻomalu hānau (nā lāʻau lapaʻau Contraceptive)

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki i nā kaola kaohi hānau ke hōʻemi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i ke kofe ʻōmaʻomaʻo me nā lāʻau kaohi hānau hiki ke kumu i ka jitteriness, headache, ka wikiwiki o ka puʻuwai, a me nā hopena ʻē aʻe.

ʻO kekahi o nā lāʻau kaohi hānau me ethinyl estradiol a me levonorgestrel (Triphasil), ethinyl estradiol a me norethindrone (Ortho-Novum 1/35, Ortho-Novum 7/7/7), a me nā mea ʻē aʻe.

Cimetidine (Tagamet)

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki i ka Cimetidine (Tagamet) ke hoʻēmi i ka wikiwiki o kou kino e wāwahi i ka caffeine. Lawe i ka cimetidine (Tagamet) me ke kofe ʻōmaʻomaʻo e hoʻonui i ka manawa o nā hopena caffeine e like me ka jitteriness, ʻeha, kuʻi wikiwiki, a me nā mea ʻē aʻe.

ʻO Fluconazole (Diflucan)

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki i ka Fluconazole (Diflucan) ke hoʻoliʻiliʻi i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka caffeine. Lawe i ka fluconazole (Diflucan) a me ke kope ʻōmaʻomaʻo e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o ke kofe e like me ka makaʻu, ka hopohopo, a me ka hiamoe ʻole.

Nā lāʻau no ka maʻi kō (Antidiabetes lāʻau)

ʻO ka cafe i loko o ke kofe ʻōmaʻomaʻo e hoʻonui paha i ke kō kō. Hoʻohana ʻia nā lāʻau diabetes e hoʻohaʻahaʻa i ke kō kō. Ma ka hoʻonui ʻana i ke kō kō, hiki i ke kofe ʻōmaʻomaʻo ke hoʻemi i ka pono o nā lāʻau diabetes. E nānā pono i kāu kō kō. Pono e hoʻololi i ka mahele lāʻau o kāu lāʻau diabetes.

ʻO kekahi mau lāʻau i hoʻohana ʻia no ka maʻi kō me glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), a me kekahi .

Nā lāʻau no ke koko kiʻekiʻe (Antihypertensive lāʻau lapaʻau)

Hiki i ke kofe ʻōmaʻomaʻo ke hoʻemi i ke kaomi koko. ʻO ka lawe ʻana i ke kofe ʻōmaʻomaʻo me nā lāʻau no ke koko kiʻekiʻe e hoʻohaʻahaʻa loa i kou kahe koko.

ʻO kekahi mau lāʻau no ke koko kiʻekiʻe me captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), Amlodipine (Norvasc), hydrochlorothiazide (HydroDIURIL), furosemide (Lasix), a me nā mea ʻē aʻe he nui. .

ʻO Mekiletine (Mexitil)

Loaʻa i ka kope ʻōmaʻomaʻo ka caffeine Hōʻoki ke kino i ka caffeine e kāpae iā ia. Hiki i ka Mexiletine (Mexitil) ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana iā Mexiletine (Mexitil) me ke kope ʻōmaʻomaʻo e hoʻonui paha i nā hopena ʻē aʻe e pili ana i ka caffeine o ke kofe ʻōmaʻomaʻo.

Terbinafine (Lamisil)

Hōʻoki ke kino i ka caffeine i loko o ka kofe ʻōmaʻomaʻo e kāpae iā ia. Hiki iā Terbinafine (Lamisil) ke hoʻēmi i ka wikiwiki o ke kino e hoʻopau i ka caffeine a hoʻonui i ka hopena o nā hopena ʻē aʻe e like me ka jitteriness, headache, hoʻonui i ka puʻuwai puʻuwai, a me nā hopena ʻē aʻe

ʻAlani ʻawahia

ʻO ka ʻalani ʻawaʻawa me ka caffeine a i ʻole caffeine-i loaʻa nā mea kanu hiki ke hoʻonui i ke kahe o ke koko a me ka helu o ka puʻuwai i nā mākua olakino ʻē aʻe me ke kaomi koko maʻamau. Hoʻonui paha kēia i ka makaʻu o ka hoʻomohala ʻana i nā pilikia puʻuwai koʻikoʻi. Hōʻalo i kēia hui ʻana.

Loaʻa nā mea kanu a me nā mea hoʻopili i ka cafe

ʻO ka hoʻohana ʻana i ke kofe ʻōmaʻomaʻo me nā mea kanu ʻē aʻe me ka caffeine a me nā mea hoʻopihapiha e hoʻonui ai i ka caffeine a hoʻonui i ka hopena o ka hopena ʻana i nā hopena ʻē aʻe e pili ana i ka caffeine. ʻO nā lāʻau lapaʻau ʻē aʻe i loko o ka caffeine e komo pū me ka tī ʻeleʻele, cocoa, cola nut, kī ʻōmaʻomaʻo, tī oolong, guarana, a me kou hoa.

Kalipuna

ʻO ka lawe ʻana i ka caffeine kiʻekiʻe mai nā meaʻai a me nā mea inu me ka kofe ʻōmaʻomaʻo e hoʻonui i ka nui o ka puna i hoʻoheheʻe ʻia i ka mimi.

Cyclodextrin

Ua hōʻike ʻia ka cyclodextrin fiber fiber i ka paʻakikī me kekahi mau ʻāpana o ke kofe ʻōmaʻomaʻo nāna ke kuleana no kāna hopena hoʻohaʻahaʻa koko. ʻO ke kaulike, ʻo ka ʻai ʻana i ka cyclodextrin a me ke kofe ʻōmaʻomaʻo e hoʻoliʻiliʻi ai i ka lawe ʻana o kēia mea a hoʻoliʻiliʻi i nā hopena maikaʻi i ke kaomi koko.

Ephedra (Ma huang)

Aia i loko o ke kofe ʻōmaʻomaʻo ka caffeine, kahi mea hōʻeuʻeu. Ke hoʻohana nei i ka kofe ʻōmaʻomaʻo me ka ephedra, kahi mea hoʻonāukiuki hoʻi, e hoʻonui paha i ka hopena o ka hopena i nā hopena ʻino a hoʻoweliweli paha e like me ke koko kiʻekiʻe, ka puʻuwai puʻuwai, ka hahau, ka hopu ʻana, a me ka make. Pale i ka lawe kope me ka ephedra a me nā mea stimulants ʻē aʻe.

ʻO nā lau nahele a me nā mea hoʻopili e hoʻoliʻiliʻi i ke kahe o ke koko

Hoʻoemi ke kope ʻōmaʻomaʻo i ke kaomi koko. Ke hoʻohana ʻia me nā mea kanu ʻē aʻe a me nā mea hoʻopihapiha e hōʻemi i ke kaomi koko, loaʻa paha i nā kope ʻōmaʻomaʻo nā hopena hoʻohaʻahaʻa i ke kaomi o ke koko. ʻO nā lāʻau kūlohelohe ʻē aʻe me ke kaomi hoʻohaʻahaʻa ʻana i ke koko e komo pū me ka alpha-linolenic acid, blsy psyllium, calcium, cocoa, cod ate aila, coenzyme Q-10, kālika, ʻoliva, potassium, pycnogenol, ʻalani ʻalani, wikamina C, bran palaoa, a me nā mea ʻē aʻe. .

ʻO nā lau nahele a me nā mea hoʻopili e hoʻoliʻiliʻi ai i ke kō kō

Hiki i ka ʻope kope ʻōmaʻomaʻo ke hoʻohaʻahaʻa i ke kiʻekiʻe o ke kō glucose. ʻO ka hoʻohana ʻana ia me nā mea kanu ʻē aʻe a i ʻole nā ​​mea hoʻopihapiha i loaʻa ka hopena like e hoʻoliʻiliʻi haʻahaʻa ai nā pae kō kō. ʻO kekahi mau mea kanu a me nā mea hoʻopihapiha i hiki ke hoʻohaʻahaʻa i ke kō i ke kō me ka alpha-lipoic acid, chromium, ka māiʻuʻu diabolō, fenugreek, kālika, ka gum gum, ka chestnut lio, ginseng Panax, psyllium, ginseng Siberian, a me nā mea ʻē aʻe.

ʻO nā lau nahele a me nā mea hoʻopili e lohi ai i ke kāpili ʻana o ke koko

ʻO ka caffeine i loko o ke kofe ʻōmaʻomaʻo e hoʻolohi i ke kō ʻana o ke koko. Lawe i ka kofe ʻōmaʻomaʻo a me ka hoʻohana ʻana i nā mea kanu i hiki ke lohi i ke kāpili ʻana o ke koko i hiki ke hoʻonui i ka makaʻu o ke kahe ʻana i kekahi poʻe. ʻO kekahi o kēia mau mea kanu e komo pū me angelica, clove, danshen, kālika, ginger, ginkgo, Panax ginseng, a me nā mea ʻē aʻe.

Mea hao

Hiki i kekahi mau ʻāpana o ke kofe ʻōmaʻomaʻo ke pale i ka hao mai ka lawe ʻia ʻana mai ka meaʻai. Theoretically, hopena paha kēia i nā pae o ka hao i ke kino e lilo i haʻahaʻa loa.

Makanekiuma

Hiki i ka lawe ʻana i ka nui o ke kofe ʻōmaʻomaʻo ke hoʻonui i ka nui o ka magnesi i hoʻoheheʻe ʻia i ka mimi.

Melatonin

ʻO ka lawe ʻana i ka caffeine a me melatonin pū hiki ke hoʻonui i nā pae melatonin.

ʻAʻole ʻike ʻia nā launa me nā meaʻai.

ʻO ka mahele kūpono o ke kofe ʻōmaʻomaʻo e kaukaʻi ʻia i nā kumu like ʻole e like me ka makahiki o ka mea hoʻohana, olakino, a me nā ʻano ʻē aʻe. I kēia manawa ʻaʻole lawa ka ʻike ʻepekema e hoʻoholo ai i kahi pae kūpono no nā kope ʻōmaʻomaʻo (i nā keiki / i nā mākua). E hoʻomanaʻo i ka pono ʻole o ka palekana i nā huahana kūlohelohe a hiki i nā dosages ke koʻikoʻi. E mālama pono i nā ʻōkuhi pili i nā lepili huahana a nīnau i kāu kauka lāʻau a i ʻole kauka a i ʻole ʻoihana olakino ʻē aʻe ma mua o ka hoʻohana ʻana.

ʻO Caféea Green Coffee Beans, Café Marchand, Café Verde, Café Vert, Coffea arabica, Coffea arnoldiana, Coffea bukobensis, Coffea canephora, Coffea liberica, Coffea robusta, Extrait de Café Vert, Extrait de Fève de Café Vert, Fèves de Café Vert, Fèves de Café Vert Arabica, Fèves de Café Vert Robusta, GCBE, GCE, Green Coffee Beans, Green Coffee Bean Extract, Green Coffee Extract, Green Coffee Powder, Poudre de Café Vert, Raw Coffee, Mea Kope Kope Raw, Robusta Green Coffee Beans, Svetol .

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. ʻO Roshan H, Nikpayam O, Sedaghat M, Sohrab G. Nā hopena o ke kīʻaha kope ʻōmaʻomaʻo ma nā ʻikepili anthropometric, kaohi glycemic, kahe koko, pili lipid, ke kūpaʻa ʻana o ka insulin a me ka makemake i nā mea maʻi me ka metabolic syndrome. ʻO Br J Nutr. 2018; 119: 250-258. Nānā kiʻi ʻole.
2. Chen H, Huang W, Huang X, et al. Nā hopena o ka ʻemi pīni kope ʻōmaʻomaʻo ma nā pae protein C-reactive: kahi loiloi ʻōnaehana a me ka meta-aniani o nā hoʻokolohua hoʻokolohua kaulike ʻia. Hoʻohui Ther Med. 2020; 52: 102498. Nānā kiʻi ʻole.
3. ʻO Twaruzek M, Kosicki R, Kwiatkowska-Gizynska J, Grajewski J, Altyn I. Ochratoxin A a me citrinin i loko o ke kope ʻōmaʻomaʻo a me nā mea hoʻopihapihaʻai me ka wai kope ʻōmaʻomaʻo. Toxicon. 2020; 188: 172-177. Nānā kiʻi ʻole.
4. ʻO Nikpayam O, Najafi M, Ghaffari S, Jafarabadi MA, Sohrab G, Roshanravan N. Nā hopena o ka wai kope ʻōmaʻomaʻo i ka hoʻokēʻai ʻana i ka glucose koko, ka noʻonoʻo o ka insulin a me ka loiloi hoʻohālikelike homeostatic o ke kūpaʻa ʻana o ka insulin (HOMA-IR). o nā noi komo. ʻO Diabetol Metab Syndr. 2019; 11: 91. Nānā kiʻi ʻole.
5. ʻO Martínez-López S, Sarriá B, Mateos R, Bravo-Clemente L. ʻO ka ʻai kūpono ʻana o kahi kope ʻōmaʻomaʻu i hoʻomoʻa ʻia i waiwai ʻia i nā waikawa caffeoylquinic e hoʻemi ana i nā hōʻailona pilikia o ka maʻi puʻuwai. . ʻO Eur J Nutr. 2019; 58: 865-878. Nānā kiʻi ʻole.
6. Asbaghi ​​O, Sadeghian M, Rahmani S, et al. Ka hopena o ke kope ʻōmaʻomaʻo e hoʻopiha i nā ana anthropometric i nā mākua: He loiloi ʻōnaehana piha a me ka meta-pane ana i nā hoʻokolohua hoʻokolohua. Hoʻohui Ther Med. 2020; 51: 102424. Nānā kiʻi ʻole.
7. ʻO Cozma-Petrut A, Loghin F, Miere D, Dumitrascu DL. ʻO Diet i ka maʻi huhū huhū: He aha ka mea e paipai ai, ʻaʻole ka mea e pāpā aku ai i nā mea maʻi! Honua J Gastroenterol. 2017; 23: 3771-3783. Nānā kiʻi ʻole.
8. ʻO Rao SS. Nā koho lapaʻau e kū nei a kū nei hoʻi no ka incontinence fecal. ʻO J Clin Gastroenterol. 2014; 48: 752-64. Nānā kiʻi ʻole.
9. Wikoff D, Welsh BT, Henderson R, et al. ʻO ka loiloi ʻōnaehana o nā hopena maikaʻi ʻole o ka ʻai ʻana o ka caffeine i nā mākua olakino, nā wahine hāpai, nā ʻōpio, a me nā keiki. Nā Mea Hana Meaola Toxicol 2017; 109: 585-648. Nānā kiʻi ʻole.
10. Cappelletti S, Piacentino D, Fineschi V, Frati P, Cipollini L, Aromatario M. Nā make pili i ka Caffeine: ke ʻano o ka make a me nā ʻano o ka makaʻu. Nutrients. 2018 Mei 14; 10. pii: E611. Nānā kiʻi ʻole.
11. Magdalan J, Zawadzki M, Skowronek R, et al. ʻO nā meaʻona ʻole nonfatal a me fata me ka caffeine maʻemaʻe - hōʻike o nā hihia ʻekolu. Forensic Sci Med Pathol. 2017 Sep; 13: 355-58. Nānā kiʻi ʻole.
12. ʻO Tejani FH, Thompson RC, Kristy R, Bukofzer S. Ka hopena o ka caffeine ma SPECT myocardial perfusion kiʻi i ka regadenoson pharmacologic stress: kahi prospective, randomized, multicenter study. ʻO Int J Cardiovasc Imaging. 2014 Iune; 30: 979-89. hana: 10.1007 / s10554-014-0419-7. Epub 2014 17. Nānā i ka abstract.
13. ʻO Poussel M, Kimmoun A, ʻo Levy B, ʻo Gambier N, ʻo Dudek F, ʻo Puskarczyk E, ʻo Poussel JF, ʻo Chenuel B. ʻO ka arrhythmia puʻuwai puʻuwai e pili ana i ka overdosis o ka caffeine manawaleʻa i ka mea haʻuki kino hana kino. Int J Cardiol. 2013 1; 166: e41-2. hana: 10.1016 / j.ijcard.2013.01.238. Epub 2013 7. ʻAʻohe abstract i loaʻa. Nānā kiʻi ʻole.
14. ʻO Jabbar SB, Hanly MG. ʻO ka overdosis caffeine make: kahi hōʻike hihia a me ka loiloi o nā puke. ʻO Am J Forensic Med Pathol. 2013; 34: 321-4. hana: 10.1097 / PAF.0000000000000058. Loiloi. Nānā kiʻi ʻole.
15. ʻO Bonsignore A, Sblano S, Pozzi F, Ventura F, DellʻErba A, Palmiere C. He hihia pepehi kanaka ma ka ʻai ʻana i ka caffeine. Forensic Sci Med Pathol. 2014 Sep; 10: 448-51. hana: 10.1007 / s12024-014-9571-6. Epub 2014 27. E nānā abstract.
16. Beaudoin MS, Allen B, Mazzetti G, Sullivan PJ, Graham TE. Hoʻopilikia kaʻai ʻana i ka cafeeine i ka noʻonoʻo ʻana o ka insulin i kahi ʻano hilinaʻi ʻia i nā kāne a me nā wahine. ʻOihana Physiol Nutr Metab. 2013; 38: 140-7. hana: 10.1139 / apnm-2012-0201. Epub 2012 9. Nānā i ka abstract.
17. Pahu ʻIke Huahana Svetol. ʻO Naturex, Avignon, Palani. Malaki 2013. Loaʻa ma: http://greencafé.gr/wp-content/uploads/2013/12/GA501071_PRODUCT-INFO-PACK_04-06-2013.pdf (kiʻi ʻia i Iulai 6, 2015).
18. ʻO Vinson J, Burnham B. Hoʻihoʻi hou: Randomized, double-blind, placebo-control, linear dose, crossover study e loiloi i ka pono a me ka palekana o kahi ʻōpuna kope kī ʻōmaʻomaʻo i nā mea kaumaha. ʻO Diabetes Metab Syndr Obes 2014; 7: 467. Loaʻa ma: www.ncbi.nlm.nih.gov/pmc/articles/PMC4206203/.
19. Hoʻolaha ka Federal Trade Commission. Hoʻonohonoho ka mea hana hua kope ʻōmaʻomaʻo FTC i ka uku no ka hoʻokau ʻana i kāna huahana e pili ana i nā hopena o ka "kaumaha maikaʻi" ʻana. Loaʻa ma: www.ftc.gov/news-events/press-releases/2014/09/green-café-bean-manufaktur-settles-ftc-charges-pushing-its (kiʻi ʻia i Iulai 5, 2015).
20. Saito, T., Tsuchida, T., Watanabe, T., Arai, Y., Mitsui, Y., Okawa, W., a me Kajihara, Y. Ka hopena o ke kīʻaha pīni kope i ke kiʻekiʻe kiʻekiʻe. ʻO Jpn J Med Pharm Sci 2002; 47: 67-74.
21. Blum, J., Lemaire, B., a me Lafay, S. Ka hopena o kahi ʻōmaʻomaʻo kope decaffeined ʻōmaʻomaʻo ma glycaemia: kahi noiʻi prospective prospective. Nā Nutrafoods 2007; 6: 13-17.
22. ʻO Dellalibera, O., Lemaire, B., a me Lafay, S. Svetol®, kaomi kope ʻōmaʻomaʻo, hoʻonāukiuki i ka pohō a hoʻonui i ka lōlō i ka lakio papaha momona i nā mea manawaleʻa me ka pilikia kaumaha. Phytotherapie 2006; 4: 1-4.
23. ʻO Arion, WJ, Canfield, WK, Ramos, FC, Schindler, PW, Burger, HJ, Hemmerle, H., Schubert, G., Ma lalo, P., a me Herling, AW Chlorogenic acid a me hydroxynitrobenzaldehyde: mea hou nā glucose hepatic 6 -phosphatase. Arch.Biochem.Biophys. 3-15-1997; 339: 315-322. Nānā kiʻi ʻole.
24. Peyresblanques, J. [Pākuʻi Conjunctival i ke kope ʻōmaʻomaʻo]. Bull.Soc.Ophtalmol.Fr. 1984; 84: 1097-1098. Nānā kiʻi ʻole.
25. ʻO Franzke, C., Grunert, K. S., Hildebrandt, U., a me Griehl, H. [Ma ka theobromine a me nā ʻike theophylline o ka kope maka a me ke kī]. Pharmazie 9-9-1968; 23: 502-503. Nānā kiʻi ʻole.
26. Zuskin, E., Kanceljak, B., Skuric, Z., a me Butkovic, D. Bronchial reactivity i ka hōʻike kope ʻōmaʻomaʻo. Br.J.Ind.Med. 1985; 42: 415-420. Nānā kiʻi ʻole.
27. Uragoda, C. G. Huʻi koʻikoʻi i nā limahana kope. J.Trop.Med.Hyg. 1988; 91: 169-172. Nānā kiʻi ʻole.
28. Suzuki, A., Fujii, A., Jokura, H., Tokimitsu, I., Hase, T., a me Saito, I. Hoʻopilikia ʻo Hydroxyhydroquinone i ka hoihoi ʻia ʻana o ka hana endothelial i ka acidic acidic chlorogen i hana ʻia endothelial i nā ʻiole hypertensive spontan. Am.J.Hypertens. 2008; 21: 23-27. Nānā kiʻi ʻole.
29. Selmar, D., Bytof, G., a me Knopp, S. E. Ka mālama ʻana i ke kope ʻōmaʻomaʻo (Coffea arabica): ka hoʻoliʻiliʻi o ka hiki a me nā loli o ka mua o ka ʻaʻala. ʻO Ann.Bot. 2008; 101: 31-38. Nānā kiʻi ʻole.
30. Oka, K. [Nā kumu lāʻau pharmacological o nā meaʻai kope no ka pale ʻana i ka maʻi kō. Yakugaku Zasshi 2007; 127: 1825-1836. Nānā kiʻi ʻole.
31. Takahama, U., Ryu, K., a me Hirota, S.Hiki i ka Chlorogenic acid i ke kofe ke pale i ke kūkulu ʻia ʻana o dinitrogen trioxide e ka scavenging nitrogen dioxide i hana ʻia i loko o ka lua waha o ke kanaka. J.Agric. Meaʻai Kemika. 10-31-2007; 55: 9251-9258. Nānā kiʻi ʻole.
32. ʻO Monteiro, M., Farah, A., Perrone, D., Trugo, L. C., a me Donangelo, C. Chlorogenic acid compound mai ka kofe i ʻokoʻa lawe ʻia a metabolised i nā kānaka. J.Nutr. 2007; 137: 2196-2201. Nānā kiʻi ʻole.
33. ʻO Glei, M., Kirmse, A., Habermann, N., Persin, C., a me Pool-Zobel, B. L. ʻO ka palaoa i hoʻonui ʻia me ka wai kope ʻōmaʻomaʻo i loaʻa nā hana chemoprotective a antigenotoxic i nā hunaola kanaka. Nutr.Cancer 2006; 56: 182-192. Nānā kiʻi ʻole.
34. Greenberg, J. A., Boozer, C. N., a me Geliebter, A. Kope, diabetes, a me ka kaohi kaupaona. Am.J.Clin.Nutr. 2006; 84: 682-693. Nānā kiʻi ʻole.
35. Suzuki, A., Fujii, A., Yamamoto, N., Yamamoto, M., Ohminami, H., Kameyama, A., Shibuya, Y., Nishizawa, Y., Tokimitsu, I., and Saito, I. ʻO ka hoʻomaikaʻi ʻana o ka hypertension a me ka hana ʻole o ke kino e ka hydroxyhydroquinone-kope kope i kahi ʻano genetical o hypertension. FEBS Lett. 4-17-2006; 580: 2317-2322. Nānā kiʻi ʻole.
36. Higdon, J. V. a me Frei, B. Kope a me ke olakino: kahi loiloi i ka noiʻi kanaka hou. ʻO Crit Rev.Food Sci.Nutr. 2006; 46: 101-123. Nānā kiʻi ʻole.
37. ʻO Glauser, T., Bircher, A., a me Wuthrich, B. [Allergic rhinoconjunctivitis i hoʻokumu ʻia e ka lepo o nā pīni kope ʻōmaʻomaʻo]. ʻO Schweiz.Med.Wochenschr. 8-29-1992; 122: 1279-1281. Nānā kiʻi ʻole.
38. ʻO Gonthier, M. P., Verny, M. A., Besson, C., Remesy, C., a me Scalbert, A. ʻO ka bioavailability acid Chlorogenic ka mea i hilinaʻi nui ʻia e ka microflora ʻōpū i nāʻiole. J.Nutr. 2003; 133: 1853-1859. Nānā kiʻi ʻole.
39. ʻO Olthof, M. R., Hollman, P. C., Buijsman, M. N., van Amelsvoort, J. M., a me Katan, M. B. Chlorogenic acid, quercetin-3-rutinoside a me nā phenole kī ʻeleʻele e hoʻopili nui ʻia i nā kānaka. J.Nutr. 2003; 133: 1806-1814. Nānā kiʻi ʻole.
40. Moridani, M. Y., Scobie, H., a me O'Brien, P. J. Metabolism o ka caffeic acid e nā ʻino hepatosit a me nā ʻāpana subcellular. Toxicol.Lett. 7-21-2002; 133 (2-3): 141-151. Nānā kiʻi ʻole.
41. ʻO Daglia, M., Tarsi, R., Papetti, A., Grisoli, P., Dacarro, C., Pruzzo, C., a me Gazzani, G. Antiadhesive hopena o ke kope ʻōmaʻomaʻa a me ka mea i hoʻomoʻa ʻia ma nā Streptococcus mutans 'waiwai lina ma lawai -ʻāpana manamana hydroxyapatite. J.Agric. Meaʻai Kemika. 2-27-2002; 50: 1225-1229. Nānā kiʻi ʻole.
42. Richelle, M., Tavazzi, I., a me Offord, E. Hoʻohālikelike o ka hana antioxidant o nā mea inu polyphenolic (kope, kakao, a me nā tī) i hoʻomākaukau ʻia no kēlā me kēia kīʻaha lawelawe. J.Agric. Meaʻai Kemika. 2001; 49: 3438-3442. Nānā kiʻi ʻole.
43. ʻO Couteau, D., McCartney, A. L., Gibson, G. R., Williamson, G., a me Faulds, C. B. Hoʻokaʻawale a me ka hoʻohālikelike ʻana o ka bacteria bacteria o ke kanaka i hiki ke hydrolyse i ka waikawa chlorogenic. J.Appl.Microbiol. 2001; 90: 873-881. Nānā kiʻi ʻole.
44. ʻO Daglia, M., Papetti, A., Gregotti, C., Berte, F., a me Gazzani, G. In vitro antioxidant a me nā hana palekana ex vivo o ka kofe ʻōmaʻomaʻo a me ka pūlehu ʻia. J.Agric. Meaʻai Kemika. 2000; 48: 1449-1454. Nānā kiʻi ʻole.
45. Herling, A. W., Burger, H., Schubert, G., Hemmerle, H., Schaefer, H., a me Kramer, W. Alterations o ka huʻopaʻa a me ka lipid intermediary metabolism i ka wā o ka inhibition o glucose-6-phosphatase i nāʻiole. Eur.J.Farmacol. 12-10-1999; 386: 75-82. Nānā kiʻi ʻole.
46. Bassoli, BK, Cassolla, P., Borba-Murad, GR, Constantin, J., Salgueiro-Pagadigorria, CL, Bazotte, RB, da Silva, RS, a me de Souza, HM Chlorogenic acid e hoʻemi i ka piko glucose plasma i ka waha. hoʻāʻo tolerance glucose: nā hopena ma ka hepatic glucose hoʻokuʻu a me ka glycaemia. Pūnaewele Biochem. Pau. 2008; 26: 320-328. Nānā kiʻi ʻole.
47. ʻO Almeida, A. A., Farah, A., Silva, D. A., Nunan, E. A., a me Gloria, M. B. Hana Antibacterial o nā kope kope a me nā hui kemika kope i koho ʻia e pili ana i ka enterobacteria. ʻO J Agric.Food Chem 11-15-2006; 54: 8738-8743. Nānā kiʻi ʻole.
48. Dimaio, V. J. a me Garriott, J. C. Lethal caffeine ʻona i loko o kahi keiki. Forensic sci. 1974; 3: 275-278. Nānā kiʻi ʻole.
49. ʻO Alstott, R. L., Miller, A. J., a me Forney, ʻo R. B. Hōʻike o kahi make kanaka ma muli o ka caffeine. ʻO J.Forensic Sci. 1973; 18: 135-137. Nānā kiʻi ʻole.
50. Orozco-Gregorio, H., Mota-Rojas, D., Bonilla-Jaime, H., Trujillo-Ortega, ME, Becerril-Herrera, M., Hernandez-Gonzalez, R., a me Villanueva-Garcia, D. Nā hopena o ka lawelawe ʻana i ka caffeine ma nā loli metabolic i nā puaʻa neonatal me ka asphyxia peripartum. ʻO Am.J Vet.Res. 2010; 71: 1214-1219. Nānā kiʻi ʻole.
51. Thelander, G., Jonsson, A. K., Personne, M., Forsberg, G. S., Lundqvist, K. M., and Ahlner, J. Caffeine fatalities - ke pale aku nei nā mea kūʻai aku i nā ʻona ʻona? ʻO Clin Toxicol. (Phila) 2010; 48: 354-358. Nānā kiʻi ʻole.
52. ʻO Buscemi, S., Verga, S., Batsis, JA, Donatelli, M., Tranchina, MR, Belmonte, S., Mattina, A., Re, A., a me Cerasola, G. Nā hopena koʻikoʻi o ke kofe i ka hana endothelial i nā kumuhana olakino. ʻO Eur.J Clin Nutr. 2010; 64: 483-489. Nānā kiʻi ʻole.
53. Rudolph, T. a me Knudsen, K. He hihia no ka make ʻana o ka caffeine make. ʻO Acta Anaesthesiol. Manaʻo 2010; 54: 521-523. Nānā kiʻi ʻole.
54. ʻO Moisey, L. L., Robinson, L. E., a me Graham, T. E. ʻO ka ʻai ʻana i ke kofe caffeine a me kahi pāʻina ʻaihue kiʻekiʻe e hoʻopili ai i ka metabolism postprandial o kahi hoʻokolohua tolerance glucose waha ma hope i nā kāne kāne olakino. ʻO Br.J Nutr. 2010; 103: 833-841. Nānā kiʻi ʻole.
55. MacKenzie, T., Comi, R., Sluss, P., Keisari, R., Manwar, S., Kim, J., Larson, R., a me Baron, JA Metabolic a me nā hopena hormonal o ka caffeine: randomized, double- Hoʻokolokolo makapo, placebo-kāohi hoʻokolokolo. Metabolism 2007; 56: 1694-1698. Nānā kiʻi ʻole.
56. van Dam, R. M. Kope a me ka maʻi ʻaʻano 2: mai nā pīni a i nā beta-cells. ʻO Nutr Metab Cardiovasc.Dis. 2006; 16: 69-77. Nānā kiʻi ʻole.
57. Smits, P., Temme, L., a me Thien, T. ʻO ka laulima cardiovascular ma waena o ka caffeine a me ka nikotine i loko o nā kānaka. ʻO Clin Pharmacol Ther 1993; 54: 194-204. Nānā kiʻi ʻole.
58. Liu, T. T. a me Liau, ʻo J. Caffeine e hoʻonui i ka linearity o ka pane BOLD ʻike. Neuroimage. 2-1-2010; 49: 2311-2317. Nānā kiʻi ʻole.
59. ʻO Ursing, C., Wikner, J., Brismar, K., a me Rojdmark, S. Caffeine e hoʻāla i ka pae seraton melatonin i nā kumuhana olakino: kahi hōʻailona o ka melatonin metabolism e cytochrome P450 (CYP) 1A2. J.Endocrinol. Hoʻokomo i 2003; 26: 403-406. Nānā kiʻi ʻole.
60. Hartter, S., Nordmark, A., Rose, D. M., Bertilsson, L., Tybring, G., a me Laine, K. Nā hopena o ka lawe ʻana i ka caffeine ma nā pharmacokinetics o melatonin, kahi lāʻau lapaʻau probe no ka hana CYP1A2. ʻO Br.Jlinlin.Farmacol. 2003; 56: 679-682. Nānā kiʻi ʻole.
61. ʻO Gasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, WA, Kleinrok, Z., a me Czuczwar, SJ Felbamate e hōʻike nei i ka haʻahaʻa haʻahaʻa no ka launa pū ʻana me methylxanthines a me Ca2 + mau modulator e kūʻē i ka hopu ʻana i ka iʻa i nāʻiole. . Eur.J Pharmacol 7-10-1998; 352 (2-3): 207-214. Nānā kiʻi ʻole.
62. ʻO Vaz, J., Kulkarni, C., David, J., a me Joseph, T. Ka hopena o ka caffeine ma ka hopena o ka pharmacokinetic o ka sodium valproate a me ka carbamazepine i nā manawaleʻa kanaka maʻamau. ʻO India J.Exp.Biol. 1998; 36: 112-114. Nānā kiʻi ʻole.
63. ʻO Chroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., a me Czuczwar, S. J. Caffeine a me ka ikaika anticonvulsant o nā lāʻau antiepileptic: ʻike hoʻokolohua a me ka maʻi. ʻO Pharmacol. Rep. 2011; 63: 12-18. Nānā kiʻi ʻole.
64. ʻO Luszczki, J. J., Zuchora, M., Sawicka, K. M., Kozinska, J., a me Czuczwar, ʻo S. J. ʻO ka ʻike nui ʻana i ka caffeine e hoʻemi ana i ka hana anticonvulsant o ka ethosuximide, akā ʻaʻole ka clonazepam, phenobarbital a me valproate e kūʻē i ka hopu ʻana o pentetrazole i nāʻiole. Repubalika Pharmacol. 2006; 58: 652-659. Nānā kiʻi ʻole.
65. Jankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., a me Czuczwar, S. J. [Caffeine a me nā lāʻau antiepileptic: nā hōʻike hoʻokolohua a me nā ʻike maʻi]. Przegl.Lek. 2007; 64: 965-967. Nānā kiʻi ʻole.
66. ʻO Gasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., a me Czuczwar, S. J. Anticonvulsant hana o phenobarbital a me valproate e pili ana i ka electroshock maximal i nāʻiole i ka wā o ka mālama mau ʻana me ka caffeine a me ka hoʻopau ʻana o ka caffeine. Epilepsia 1996; 37: 262-268. Nānā kiʻi ʻole.
67. Fuhr, U., Strobl, G., Manaut, F., Anders, EM, Sorgel, F., Lopez-de-Brinas, E., Chu, DT, Pernet, AG, Mahr, G., Sanz, F. , a. Nā ʻākena antibacterial Quinolone: ​​ka pilina ma waena o ka hanana a me ka in vitro inhibition o ka cytochrome P450 kanaka isoform CYP1A2. Mol.Pharmacol. 1993; 43: 191-199. Nānā kiʻi ʻole.
68. ʻO Stille, W., Harder, S., Mieke, S., Beer, C., Shah, P. M., Frech, K., a me Staib, A. H. Ka hoʻemi ʻana i ka hoʻopau caffeine i loko o ke kanaka i ka wā o ke alakaʻi ʻana o 4-quinolones. J. ʻAntimicrob. Luna 1987; 20: 729-734. Nānā kiʻi ʻole.
69. Staib, A. H., Stille, W., Dietlein, G., Shah, P. M., Harder, S., Mieke, S., a me Beer, C. Ka launa pū ma waena o ka quinolones a me ka caffeine. Nā lāʻau 1987; 34 Hōʻuluʻulu 1: 170-174. Nānā kiʻi ʻole.
70. Kynast-Gales SA, Massey LK. Ka hopena o ka caffeine ma ka excretion o ka urinary calcium a me ka magnesium. ʻO J Am Coll Nutr. 1994; 13: 467-72. Nānā kiʻi ʻole.
71. Irwin PL, King G, Hicks KB. ʻO Polymerized cyclomaltoheptaose (beta-cyclodextrin, beta-CDn) hoʻokomo pū ʻia me ka waikawa chlorogenic: nā hopena hoʻoheheʻe ʻia ma ka thermochemistry a me ka uku entalpy-entropy. ʻO Carbioxid Res. 1996 Pep 28; 282: 65-79. Nānā kiʻi ʻole.
72. Irwin PL, Pfeffer PE, Doner LW, a me al. ʻO ka hoʻopili ʻana i ka geometry, stoichiometry, a me nā thermodynamics o cyclomalto-oligosaccharide (cyclodextrin) me ka hoʻohui pū me ka acidic chlorogenic, ka mea nui o ka ʻapila polyphenol oxidase. ʻO Carbioxid Res. 1994 Mar 18; 256: 13-27. Nānā kiʻi ʻole.
73. Moreira DP, Monteiro MC, Ribeiro-Alves M, et al. Ka hāʻawi ʻana o nā waikawa chlorogenic i ka hana hoʻoliʻiliʻi hao o nā mea inu kope. ʻO J Agric Meaʻai Kemika. 2005 Malaki 9; 53: 1399-402. Nānā kiʻi ʻole.
74. Hurrell RF, Reddy M, Kuke JD. Ka pāpā ʻana i ka lawe ʻole ʻana o ka hao hao ʻole i ke kanaka e nā mea inu me nā polyphenolic. Br J Nutr 1999; 81: 289-95. Nānā kiʻi ʻole.
75. van Rooij J, van der Stegen GH, Schoemaker RC, et al. Ke aʻo like ʻana me kahi placebo o ka hopena o ʻelua ʻano o ka aila kope ma nā lipid serum a me nā transaminase: ʻike ʻia o nā mea kemika i pili i ka hopena koleke o ka kope. ʻO Am J Clin Nutr. 1995 Jun; 61: 1277-83. Nānā kiʻi ʻole.
76. - Jackson, L. S. a me Lee, K. Nā ʻano kemika o ka hao, calcium, magnesium a me zinc i loko o ke kofe a me nā ʻai ʻiole i piha i ke kope. J-Food-Prot .mes, Iowa: International Association of Milk, Meaʻai, a me nā Kaiāulu Sanitarians 1988; 51: 883-886.
77. Pereira MA, Parker ED, a me Folsom AR. ʻO ka ʻai ʻana o ka kofe a me ka makaʻu o ka maʻi diabetes type 2: he 11-makahiki prospective study o 28 812 wahine postmenopausal. ʻO Arch Intern Med. 2006 Jun 26; 166: 1311-6. Nānā kiʻi ʻole.
78. Johnston KL, Clifford MN, Morgan LM. Hoʻololi pono ke kofe i ka huna ʻana o ka hormone gastrointestinal a me ka hoʻomanawanui ʻana o ka glucose i nā kānaka: nā hopena glycemic o ka chlorogenic acid a me ka caffeine. ʻO Am J Clin Nutr. 2003ʻOkakopa; 78: 728-33. Nānā kiʻi ʻole.
79. Keijzers GB, De Galan BE, Tack CJ, et al. Hiki i ka cafe ke hōʻemi i ka ʻike o ka insulin i loko o ke kanaka. Mālama Diabetes. 2002 Pepeluali; 25: 364-9. Nānā kiʻi ʻole.
80. Greer F, Hudson R, Ross R, et al. Hoʻemi ka ʻai ʻana i ka caffeine i ka hoʻolei ʻana o ka kōpika i ka wā o ka paʻa hyperinsulinemic-euglycemic i nā kānaka noho. Diabetes. 2001 ʻOkakopa; 50: 2349-54. Nānā kiʻi ʻole.
81. ʻO Thong FS lāua ʻo Graham TE. Hoʻopau ʻia ka hoʻowahāwahā ʻia o ka ʻaukake glucose e ka cafe i hoʻopau ʻia e ka beta-adrenergic receptor blockade i loko o nā kānaka. ʻO J Appl Physiol. 2002 Jun; 92: 2347-52. Nānā kiʻi ʻole.
82. Suzuki A, Kagawa D, Ochiai R, et al. Loaʻa ka hopena kope kī ʻōmaʻomaʻo a me nā metabolites i kahi hopena i loaʻa ʻole i nā ʻiole hypertensive. ʻO Hypertens Res. 2002 Ian; 25: 99-107. Nānā kiʻi ʻole.
83. ʻO Blum J, Lemaire B, a me Lafay S. Ka hopena o kahi kope kope decaffeined ʻōmaʻomaʻo ma glycaemia: kahi noiʻi prospective prospective. Nā Nutrafoods 2007; 6: 13-17.
84. Yamaguchi T, Chikama A, Mori K, et al. ʻO ke kofe Hydroxyhydroquinone-ʻole: kahi makapō makapō-makapō, hoʻopaʻa ʻia me ka lāʻau maʻamau i pane ʻia i ka kaomi koko. ʻO Nutr Metab Cardiovasc Dis. 2008 Jul; 18: 408-14. Nānā kiʻi ʻole.
85. Olthol MR, Hollman PCH, Katan MB. Hoʻomoʻa ʻia ʻo Chlorogenic acid a me ka caffeic acid i loko o ke kanaka. ʻO J Nutr 2001; 131: 66-71. Nānā kiʻi ʻole.
86. ʻO Vinson JA, Burnham BR, Nagendran MV. Hoʻopaʻa kaulua ʻia, pālua makapō, kaohi placebo, ka lālani linear, hoʻopaʻa haʻawina crossover e loiloi i ka pono a me ka palekana o kahi ʻeke pīni kope ʻōmaʻomaʻo i nā kumuhana kaumaha. ʻO Diabetes Metab Syndr Obes 2012; 5: 21-7. Nānā kiʻi ʻole.
87. ʻO Dellalibera O, Lemaire B, Lafay S. Svetol, kaomi kope ʻōmaʻomaʻo, hoʻokomo i ka pohō o ka paona a hoʻonui i ka lōkō i ka lāki momona i nā mea manawaleʻa me ka pilikia kaumaha. Phytotherapie 2006; 4: 194-7.
88. ʻO Thom E. Ka hopena o ka chlorogen acid i hoʻonui i ka kope ma ka lawe ʻana o ka glucose i nā mea manawaleʻa olakino a me ka hopena o ka nui o ke kino ke hoʻohana lōʻihi ʻia i ka poʻe momona a momona. ʻO J Int Med Res 2007; 35: 900-8. Nānā kiʻi ʻole.
89. ʻO Onakpoya I, Terry R, ​​Ernst E. Ka hoʻohana ʻana i ka wai kope ʻōmaʻomaʻo ma ke ʻano he kumukanawai lilo: he loiloi ʻōnaehana a me nā meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻia. Hoʻomaʻamaʻa Gastroenterol Res 2011; 2011. pii: 382852. Epub 2010 Aug 31. Nānā i ka abstract.
90. ʻO Alonso-Salces RM, Serra F, Reniero F, Héberger K. Botanical a me nā ʻano ʻāina o ka kope ʻōmaʻomaʻo (Coffea arabica a me Coffea canephora): ka loiloi ʻana i ka chemometric o ka fenolic a me ka methylxanthine. ʻO J Agric Food Chem 2009; 57: 4224-35. Nānā kiʻi ʻole.
91. Shimoda H, Seki E, Aitani M. hopena hoʻōla o ka pīni kope ʻōmaʻomaʻo i ka hōʻiliʻili momona a me ke kaupaona o ke kino i nāʻiole. Hoʻohui BMC Hoʻolaha Med 2006; 6: 9. Nānā kiʻi ʻole.
92. ʻO Farah A, Donangelo CM. Nā hui Phenolic i loko o ke kope. ʻO Braz J Plant Physiol 2006; 18: 23-36.
93. ʻO Farah A, Monteiro M, Donangelo CM, Lafay S. Chlorogenic acid mai ka wai kope ʻōmaʻomaʻo i bioavailable i loko o nā kānaka. ʻO J Nutr 2008; 138: 2309-15. Nānā kiʻi ʻole.
94. Watanabe T, Arai Y, Mitsui Y, et al. ʻO ke kaomi hoʻohaʻahaʻa o ke koko a me ka palekana o ka waikawa chlorogenic mai ka lawe ʻana i ka pīni kope ʻōmaʻomaʻo i ke kiʻekiʻe kiʻekiʻe. ʻO Clin Exp Hypertens 2006; 28: 439-49. Nānā kiʻi ʻole.
95. Kozuma K, Tsuchiya S, Kohori J, et al. ʻO ka hopena Antihypertensive o ka pīni kope ʻōmaʻomaʻo ma nā kumuhana hypertensive haʻahaʻa. ʻO Hypertens Res. 2005 Sep; 28: 711-8. Nānā kiʻi ʻole.
96. Ochiai R, Jokura H, Suzuki A, et al. Hoʻomaikaʻi ke kope pīni Green i ka vasoreactivity kanaka. ʻO Hypertens Res 2004; 27: 731-7. Nānā kiʻi ʻole.
97. ʻO Duncan L. ʻO ka pī kope ʻōmaʻomaʻo e kuni wikiwiki i ka momona. ʻO Kauka Oz Hōʻike, ʻApelila 25, 2012. Loaʻa ma: http://www.doctoroz.com/blog/lindsey-duncan-nd-cn/green-café-bean-burns-fat-fast.
98. Lake CR, Rosenberg DB, Gallant S, et al. Hoʻonui ka Phenylpropanolamine i ka pae o ka caffeine plasma. ʻO Clin Pharmacol Ther 1990; 47: 675-85. Nānā kiʻi ʻole.
99. Forrest WH Jr, Bellville JW, Brown BW Jr. ʻO ka launa pū ʻana o ka caffeine me pentobarbital ma ke ʻano he hypnotic i ka pō. Anesthesiology 1972; 36: 37-41. Nānā kiʻi ʻole.
100. Raaska K, Raitasuo V, Laitila J, Neuvonen PJ. Ka hopena o ka caffeine-i loaʻa me ka kofe decaffeinated ma nā concum clozapine serum i nā mea maʻi maʻi. Nānā Haumāna Pharmacol Toxicol 2004; 94: 13-8. Nānā kiʻi ʻole.
101. Watson JM, Sherwin RS, Deary IJ, et al. Hoʻokaʻawale ʻia o nā physiological augmented, hormonal a me nā noʻonoʻo noʻonoʻo i ka hypoglycaemia me ka hoʻohana ʻana i ka caffeine. ʻO Clin Sci (Lond) 2003; 104: 447-54. Nānā kiʻi ʻole.
102. ʻO Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. ʻO ka lawe ʻana i ka caffeine maʻamau a me ka makaʻu o ke kiʻekiʻe i nā wahine. JAMA 2005; 294: 2330-5. Nānā kiʻi ʻole.
103. ʻO Juliano LM, ʻo Griffiths RR. He loiloi koʻikoʻi no ka haʻalele ʻana o ka caffeine: ka hōʻoia empirical o nā ʻōuli a me nā hōʻailona, ​​nā hanana, ka paʻakikī, a me nā hiʻohiʻona e pili ana. Psychopharmacology (Berl) 2004; 176: 1-29. Nānā kiʻi ʻole.
104. ʻO Anderson BJ, Gunn TR, Holford NH, Johnson R. Caffeine overdose i loko o kahi pēpē pēpē: papa papa a me nā pharmacokinetics. Mālama Nui ʻo Anaesth 1999; 27: 307-11. Nānā kiʻi ʻole.
105. Leson CL, McGuigan MA, Bryson SM. ʻO ka overdose caffeine i kahi kāne ʻōpio. ʻO J Toxicol Clin Toxicol 1988; 26: 407-15. Nānā kiʻi ʻole.
106. Benowitz NL, Osterloh J, Goldschlager N, a me al. Hoʻokuʻu ʻia ka catecholamine nui mai ka lāʻau ʻino caffeine. ʻO JAMA 1982; 248: 1097-8. Nānā kiʻi ʻole.
107. Haller CA, Benowitz NL, Jacob P 3. Nā hopena Hemodynamic o ephedra-free weight-loss supplement i loko o kānaka. Am J Med 2005; 118: 998-1003 .. Nānā i ka abstract.
108. Petrie HJ, Chown SE, Belfie LM, et al. Hoʻonui ka ʻai ʻana i ka caffeine i ka pane o ka insulin i ka hoʻāʻo oral-glucose-tolerance i nā kāne momona ma mua a ma hope o ka pohō kaumaha. ʻO Am J Clin Nutr 2004; 80: 22-8. Nānā kiʻi ʻole.
109. Lane JD, Barkauskas CE, Surwit RS, Feinglos MN. Hoʻopilikia ka caffeine i ka glucose glucose i ka maʻi diabetes type 2. Nānā Diabetes 2004; 27: 2047-8. Nānā kiʻi ʻole.
110. ʻO KL Durrant. ʻIke ʻia a hūnā ʻia nā kumu lāʻau i loko o ka lāʻau, ka meaʻai, a me nā huahana kūlohelohe. ʻO J Am Pharm Assoc 2002; 42: 625-37. Nānā kiʻi ʻole.
111. ʻO Beach CA, Mays DC, Guiler RC, a me nā mea ʻē aʻe. Ka pāpā ʻana i ka hoʻopau ʻana i ka caffeine e disulfiram i nā kumuhana maʻamau a me ka hōʻola ʻana i nā mea ʻona. ʻO Clin Pharmacol Ther 1986; 39: 265-70. Nānā kiʻi ʻole.
112. Dews PB, O'Brien CP, Bergman J. Caffeine: nā hopena lawena o ka haʻalele a me nā pilikia e pili ana. Meaʻai Chem Toxicol 2002; 40: 1257-61. Nānā kiʻi ʻole.
113. Holmgren P, Norden-Pettersson L, Ahlner J. Caffeine mau mea make - ʻehā mau hōʻike hihia. Forensic Sci Int 2004; 139: 71-3. Nānā kiʻi ʻole.
114. Ke Kula Lapaʻau. ʻO Caffeine no ke Kākoʻo o ka Hana ʻana i ka Manaʻo Mental: Formulated for Military Operations. Wakinekona, DC: National Academy Press, 2001. Loaʻa ma: http://books.nap.edu/books/0309082587/html/index.html.
115. Zheng XM, Williams RC. Nā pae caffeine serum ma hope o ka pau ʻana o 24 mau hola: nā hopena maʻi ma ka dipyridamole Tl myocardial perfusion kiʻi. ʻO J Nucl Med Technol 2002; 30: 123-7. Nānā kiʻi ʻole.
116. Aqel RA, Zoghbi GJ, Trimm JR, et al. Ka hopena o ka caffeine lawelawe intravenously ma intracoronary-lawelawe ʻia adenosine-hoʻokomo ʻia hemodynamics coronary i nā mea maʻi me ka maʻi coronary artery. 'Am J Cardiol 2004; 93: 343-6. Nānā kiʻi ʻole.
117. ʻO Underwood DA. ʻO nā lāʻau hea pono e mālama ʻia ma mua o kahi kaukōloa a i ʻole hoʻāʻo koʻikoʻi koʻikoʻi? ʻO Cleve Clin J Med 2002; 69: 449-50. Nānā kiʻi ʻole.
118. Smith A. Nā hopena o ka caffeine i ka lawena kanaka. Meaʻai Chem Toxicol 2002; 40: 1243-55. Nānā kiʻi ʻole.
119. ʻO Stanek EJ, Melko GP, Charland SL. ʻO ka hana Xanthine me ka dipyridamole-thallium-201 kiʻi myocardial. ʻO ka lāʻau lapaʻau 1995; 29: 425-7. Nānā kiʻi ʻole.
120. ʻO Carrillo JA, Benitez J. ʻO nā hana pharmacokinetic koʻikoʻi ma waena o ka caffeine dietary a me nā lāʻau. ʻO Clin Pharmacokinet 2000; 39: 127-53. Nānā kiʻi ʻole.
121. ʻO Wahllander A, Paumgartner G. Ka hopena o ketoconazole a me terbinafine ma nā pharmacokinetics o ka caffeine i nā mea manawaleʻa olakino. Eur J Clin Pharmacol 1989; 37: 279-83. Nānā kiʻi ʻole.
122. ʻO Sanderink GJ, Bournique B, Stevens J, et al.Ka hoʻokomo ʻana i ka isoenzymes CYP1A kanaka i loko o ka metabolism a me nā launa lāʻau o riluzole i vitro. ʻO Pharmacol Exp Ther 1997; 282: 1465-72. Nānā kiʻi ʻole.
123. ʻO Brown NJ, Ryder D, lālā RA. ʻO ka launa lāʻau pharmacodynamic ma waena o ka caffeine a me phenylpropanolamine. ʻO Clin Pharmacol Ther 1991; 50: 363-71. Nānā kiʻi ʻole.
124. ʻO Abernethy DR, Todd EL. Ka hōʻino ʻia o ka ʻae ʻana i ka caffeine ma o ka hoʻohana mau ʻana o ka estrogen low-dose estrogen-i loaʻa i nā contraceptive waha. Eur J Clin Pharmacol 1985; 28: 425-8. Nānā kiʻi ʻole.
125. Mei DC, Jarboe CH, VanBakel AB, Williams WM. Nā hopena o ka cimetidine ma ke ʻano caffeine i nā mea puhipaka a me nā mea ʻume ʻole. ʻO Clin Pharmacol Ther 1982; 31: 656-61. Nānā kiʻi ʻole.
126. Gertz BJ, Holland SD, Kline WF, a me al. Ke aʻo ʻana i ka bioavailability waha o alendronate. ʻO Clin Pharmacol Ther 1995; 58: 288-98. Nānā kiʻi ʻole.
127. Nawrot P, Jordan S, Eastwood J, et al. Nā hopena o ka caffeine i ke olakino kanaka. Hoʻohui Hoʻohui Hoʻohui 2003; 20: 1-30. Nānā kiʻi ʻole.
128. Massey LK, Whiting SJ. Caffeine, urinary calcium, calcium metabolism a me ka iwi. ʻO J Nutr 1993; 123: 1611-4. Nānā kiʻi ʻole.
129. Infante S, Baeza ML, Calvo M, et al. ʻO Anaphylaxis ma muli o ka caffeine. Allergy 2003; 58: 681-2. Nānā kiʻi ʻole.
130. Nix D, Zelenitsky S, Symonds W, et al. ʻO ka hopena o fluconazole ma nā lāʻau lapaʻau lāʻau o ka caffeine i nā kumuhana ʻōpio a me nā ʻelemākule. ʻO Clin Pharmacol Ther 1992; 51: 183.
131. Kockler DR, McCarthy MW, Lawson CL. Ka hopu ʻana i ka hana a me ka pane ʻole ʻana ma hope o kaʻai ʻana o hydroxycut. Pharmacotherapy 2001; 21: 647-51 .. Nānā i ka abstract.
132. Massey LK. ʻO ka caffeine kahi pilikia no ka nalo ʻana o ka iwi i ka poʻe kahiko? ʻO Am J Clin Nutr 2001; 74: 569-70. Nānā kiʻi ʻole.
133. ʻO Bara AI, Barley EA. Caffeine no ka hānō. ʻO Cochrane Database Syst Rev 2001; 4: CD001112 .. Nānā i ka abstract.
134. ʻO Horner NK, Lampe JW. ʻO nā ʻano hana kūpono o ka hoʻoponopono papaʻai no nā kūlana umauma fibrocystic hōʻike i ka lawa ʻole o ka hōʻike. ʻO J Am Diet Assoc 2000; 100: 1368-80. Nānā kiʻi ʻole.
135. ʻO Bell DG, ʻo Jacobs I, ʻo Ellerington K. Ka hopena o ka caffeine a me ka hoʻopili ʻana i ka ephedrine ma ka hana hoʻoikaika anaerobic. Med Sci Sports Exerc 2001; 33: 1399-403. Nānā kiʻi ʻole.
136. Avisar R, Avisar E, Weinberger D. Ka hopena o ka ʻai kope ma ke kaomi intraocular. Ann Pharmacother 2002; 36: 992-5 .. Nānā i ka abstract.
137. ʻO Ferrini RL, ʻo Barrett-Connor E. Kaʻai caffeine a me nā pae steroid endogenous sex steroid i nā wahine postmenopausal. ʻO ka Rancho Bernardo Study. Am J Epidemiol 1996: 144: 642-4. Nānā kiʻi ʻole.
138. Olthof MR, Hollman PC, Zock PL, Katan MB. ʻO ka ʻai ʻana i nā kiʻekiʻena o nā waikawa chlorogenic, i loaʻa i ke kope, a i ʻole i nā kī ʻeleʻele e hoʻonui ai i ka plasma i ka nui o nā homocysteine ​​i loko o ke kanaka. ʻO Am J Clin Nutr 2001; 73: 532-8. Nānā kiʻi ʻole.
139. Klag MJ, Wang NY, Meoni LA, et al. Ka lawe ʻana i ka kofe a me ka makaʻu o ke kiʻekiʻe kiʻekiʻe: Ke aʻo nei ʻo John Hopkins ma mua. Arch Intern Med 2002; 162: 657-62. Nānā kiʻi ʻole.
140. Samarrae WA, Truswell AS. Ka hopena pōkole o ke kope ma ka hana fibrinolytic koko i nā mākua olakino. Atherosclerosis 1977; 26: 255-60. Nānā kiʻi ʻole.
141. ʻO Ardlie NG, Glew G, Schultz BG, Schwartz CJ. Ka pāpā a me ka hoʻohuli hou ʻana o ka hōʻiliʻili platelet e methyl xanthines. ʻO Thromb Diath Haemorrh 1967; 18: 670-3. Nānā kiʻi ʻole.
142. Ali M, Afzal M. He mea kāohi i ka thrombin stimulate platelet thromboxane hoʻokumu ʻia mai ka tī kī ʻole ʻia. Prostaglandins Leukot Med 1987; 27: 9-13. Nānā kiʻi ʻole.
143. Haller CA, Benowitz NL. ʻO nā hanana ʻōnaehana cardiovascular a me nā ʻōnaehana kikowaena e pili ana i nā mea hoʻopihapihaʻai piha me nā alkaloids ephedra. N Engl J Med 2000; 343: 1833-8. Nānā kiʻi ʻole.
144. ʻO Sinclair CJ, Geiger JD. Hoʻohana ka cafe i nā haʻuki. ʻO kahi loiloi lāʻau. ʻO J Sports Med Phys Fitness 2000; 40: 71-9. Nānā kiʻi ʻole.
145. Lloyd T, Johnson-Rollings N, Eggli DF, et al. ʻO ke kūlana iwi ma waena o nā wahine postmenopausal me nā ʻano like ʻole o ka loaʻa ʻana o ka caffeine: kahi hoʻokolokolo lōʻihi. ʻO J Am Coll Nutr 2000; 19: 256-61. Nānā kiʻi ʻole.
146. Watson JM, Jenkins EJ, Hamilton P, et al. Ka hopena o ka caffeine ma ke alapine a me ka ʻike o ka hypoglycemia i nā mea maʻi ola me ka maʻi diabetes 1. Mālama Diabetes 2000; 23: 455-9. Nānā kiʻi ʻole.
147. Hagg S, Spigset O, Mjorndal T, Dahlqvist R. Ka hopena o ka caffeine ma ka clozapine pharmacokinetics i nā mea manawaleʻa olakino. Br J Clin Pharmacol 2000; 49: 59-63. Nānā kiʻi ʻole.
148. ʻO Boozer CN, Nasser JA, Heymsfield SB, et al. Kahi lāʻau hoʻopihapiha i loaʻa iā Ma Huang-Guarana no ka pohō o ke kaupaona: kahi hoʻokolohua kaulike ʻole ʻia. Int J Obes Relat Metab Disord 2001; 25: 316-24. Nānā kiʻi ʻole.
149. Dews PB, Curtis GL, Hanford KJ, O'Brien CP. ʻO ke alapine o ka haʻalele ʻana o ka caffeine i kahi ana lehulehu a me kahi hoʻokolohua hoʻokolohua hoʻomalu makapō ʻia. ʻO J Clin Pharmacol 1999; 39: 1221-32. Nānā kiʻi ʻole.
150. Nurminen ML, Niittynen L, Korpela R, Vapaatalo H. Kope, caffeine a me ke kahe koko: he loiloi koʻikoʻi. Eur J Clin Nutr 1999; 53: 831-9. Nānā kiʻi ʻole.
151. Pollock BG, Wylie M, Stack JA, et al. Ka pāpā ʻana o ka caffeine metabolism e ka estrogen replacement therapy i nā wahine postmenopausal. ʻO J Clin Pharmacol 1999; 39: 936-40. Nānā kiʻi ʻole.
152. Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Hoʻonui ka lawe ʻana i ka caffeine i ka helu o ka nalo ʻana o ka iwi i nā wahine ʻelemākule a me nā launa pū ʻana me nā genotypes reseptor vitamin D. ʻO Am J Clin Nutr 2001; 74: 694-700. Nānā kiʻi ʻole.
153. Chiu KM. Ka hopena o nā mea hoʻopiha calcium ma ka iwi i nā wahine postmenopausal. ʻO J Gerontol A Biol Sci Med Sci 1999; 54: M275-80. Nānā kiʻi ʻole.
154. Wallach J. Ka wehewehe ʻana i nā hōʻike hōʻoia. ʻO kahi synopsis o Laboratory Medicine. Fifth ed; Boston, MA: Little Brown, 1992.
155. Hodgson JM, Puddey IB, Burke V, et al. Nā hopena i ke kaomi koko o ka inu ʻana i ka tī ʻōmaʻomaʻo a me ka ʻeleʻele. ʻO J Hypertens 1999; 17: 457-63. Nānā kiʻi ʻole.
156. Wakabayashi K, Kono S, Shinchi K, et al. ʻO ka ʻai ʻana o ka kofe maʻamau a me ke kahe o ke koko: Ke aʻo ʻana i nā luna hoʻomalu pale iā Iapana. Eur J Epidemiol 1998; 14: 669-73. Nānā kiʻi ʻole.
157. Vahedi K, Domingo V, Amarenco P, Bousser MG. ʻO ka hahau Ischemic i loko o kahi haʻuki nāna i hoʻopau i ka MaHuang extract a hana i ka monesterolate no ke bodybuilding. ʻO J Neurol Neurosurg Psychiatr 2000; 68: 112-3. Nānā kiʻi ʻole.
158. ʻO Joeres R, Klinker H, Heusler H, et al. Ka hopena o ka mexiletine ma ka hoʻopau ʻana i ka caffeine. ʻO Pharmacol Ther 1987; 33: 163-9. Nānā kiʻi ʻole.
159. ʻO Jefferson JW. ʻO ka haʻalulu lithium a me ka lawe ʻana i ka caffeine: ʻelua mau hihia o ka inu liʻiliʻi a me ka haʻalulu nui aʻe. ʻO J Clin Psychiatry 1988; 49: 72-3. Nānā kiʻi ʻole.
160. Mester R, Toren P, Mizrachi I, et al. Hoʻonui ka hoʻoneʻe ʻana i ka caffeine i nā kiʻekiʻe o ke koko lithium. Biol Psychiatry 1995; 37: 348-50. Nānā kiʻi ʻole.
161. Healy DP, Polk RE, Kanawati L, et al. Ka launa ma waena o ciprofloxacin oral a me caffeine i nā mea manawaleʻa maʻamau. Nā Antimicrob Agents Chemother 1989; 33: 474-8. Nānā kiʻi ʻole.
162. Carbo M, Segura J, De la Torre R, et al. Ka hopena o nā quinolones ma ka caffeine disposition. ʻO Clin Pharmacol Ther 1989; 45: 234-40. Nānā kiʻi ʻole.
163. Harder S, Fuhr U, Staib AH, Wolff T. Ciprofloxacin-caffeine: kahi launa lāʻau i hoʻokumu ʻia me ka hoʻohana ʻana i ka vivo a me nā noiʻi in vitro. 'Am J Med 1989; 87: 89S-91S. Nānā kiʻi ʻole.
164. ʻO McEvoy GK, hoʻoponopono. ʻO ka ʻike ʻo AHFS Ka lāʻau. Bethesda, MD: ʻAmelika Hui Pū ʻIa o Health-System Pharmacists, 1998.

Nānā hope - 03/01/2021